UK Won't Probe IBA-Mallinckrodt Deal Under Revised Rules
The U.K.'s competition authority on Monday said that it won't conduct an in-depth investigation of radiopharmaceuticals products maker IBA Molecular's $690 million purchase of Irish drugmaker Mallinckrodt PLC's nuclear imaging business,...To view the full article, register now.
Already a subscriber? Click here to view full article